-
Symbol
-
TRAW on Nasdaq
-
Investment type
-
Equity / Common stock, par value $.01 per share
-
Latest Disclosed Shares Owned
-
342,935 shares
-
Security Ownership %
-
4.3%
Ayrton Capital LLC ownership in Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW)
11 Feb 2026 - Ayrton Capital LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 342,935 shares of Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW).
This represents 4.3% ownership of the company.
In their previous filing dated 13 Feb 2025, Ayrton Capital LLC had reported owning 403,650 shares, indicating a decrease of +15%.
.